article thumbnail

Giving Caregivers a Platform: Meagan, Mother of Matt

Mad in America

For a period of four years, from 2014 through 2018 during his decline and overwhelm, Matt was prescribed five different antidepressants layered on top of one another without tapering, which ignited a cycle of adverse reactions. Thankfully, the owner of the office, a renowned bipolar expert, said he could take Matt. It was just so sad.

article thumbnail

Celebrate World Bipolar Day: Breaking Barriers and Building Awareness

World Psychiatric Association (WPA)

This initiative was born out of a council meeting of the Asian Network of Bipolar Disorder (ANBD) in 2013, at which Prof. Pichet Udomratn proposed a date to bring worldwide attention to bipolar disorder. To register your activities and share event details, please visit: [link]. Together, we can make a difference.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Iatrogenic Practices in Psychiatry: Kindling

Mad in America

To clarify this concept better, “psychosis”, “depression”, “anxiety”, “bipolar disorder”, “ADHD” and more are not disorders of organic or genetic origin, caused by “imbalances” in brain chemicals, and psychotropic drugs do not have the function of restoring any balance.

article thumbnail

Could IPT Be a Treatment Option for Autism?

International Society for Interpersonal Psychother

Mentalization is an imaginative activity about others or one self, intentional mental states of needs, desires, feelings, beliefs, goals, purposes and reasons (Channon, Crawford, Orlowska, Parikh, & Thoma, 2014; Fonagy & Bateman, 2006). 2015) and borderline personality disorder (A. Bateman, 2012). Autism Res, 11 (5), 738-754.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.